INVIA, LLC

INVIA Medical Imaging Solutions develops 4DM, an advanced nuclear cardiac imaging quantification, review, and reporting software platform with over 30 years of continuous innovation in cardiac imaging analysis. 4DM provides comprehensive workflow support across multiple cardiac imaging modalities including SPECT, PET, blood pool, inflammation, amyloidosis, viability assessment, myocardial flow and flow reserve (MFR), and hybrid CT protocols. The platform delivers approximately 200 automated measurements across eight distinct clinical workflows, enabling cardiologists to assess myocardial perfusion, function, and tissue characterization. 4DM includes integrated cardiac-specific reporting at no additional cost and seamlessly integrates with leading EHR systems (EPIC and Oracle Health) and 10+ third-party reporting partners. The company maintains a dedicated research team that continuously innovates quantification algorithms and clinical workflows, with all improvements supported by peer-reviewed published validation studies. INVIA provides comprehensive customer support through a team of 10 product specialists, all certified nuclear technologists, offering on-site training in North America and hands-on workshops at company headquarters. The software is available through direct acquisition from INVIA or via 40+ established distribution partners. The platform is widely adopted by global cardiac-health institutions for high-quality nuclear cardiac study review and clinical decision support.